hepatocellular carcinoma
Senti Biosciences, Celest Therapeutics Treat First Patient With CAR-NK Cell Therapy in China
The firms have teamed up on a Phase I trial to evaluate the off-the-shelf cell therapy SN301A in patients with advanced GPC3-expressing liver cancers.
GC Cell, Lukas Biomedical Team up to Advance Autologous Cell Therapies
The Korean and Taiwanese biotechs will share research and collaborate on clinical trials to bring their cell therapies to more patients in Southeast Asia and globally.
GC Cell, Checkpoint Therapeutics to Study Autologous Cell Therapy, Checkpoint Inhibitor Combo
The firms have ambitions to jointly develop the combination in human trials if the therapies' synergistic effect shows promise preclinically.
Geneos Therapeutics' Personalized Cancer Vaccine Induces Antitumor Responses in Clinical Study
The personalized vaccine was safe and tolerable, and showed an ability to induce neoantigen-specific T-cell responses, according to data presented at ASGCT.
GC Cell Inks Deal With CDMO BioCentriq to Bring Solid Tumor Cell Therapy to US Market
The deal gives South Korea-based GC Cell the capability to manufacture its cytokine-induced killer therapy, Immuncell-LC, in North America.